{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T20:11:58Z","timestamp":1789157518519,"version":"build-2803163510"},"posted":{"date-parts":[[2026,9,8]]},"group-title":"Cancer Biology","reference-count":84,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"NIH","award":["R01CA255742"],"award-info":[{"award-number":["R01CA255742"]}]},{"name":"NIH","award":["DP2CA271387"],"award-info":[{"award-number":["DP2CA271387"]}]},{"name":"NIH","award":["R01HL144477"],"award-info":[{"award-number":["R01HL144477"]}]},{"name":"NIH","award":["R01HL165725"],"award-info":[{"award-number":["R01HL165725"]}]},{"name":"NIH","award":["F30HL162200"],"award-info":[{"award-number":["F30HL162200"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,9,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer that accounts for nearly 20% of breast cancer diagnoses. Despite recent approvals of novel therapeutic agents for TNBC, neoadjuvant chemotherapy remains part of standard of care treatment for TNBC patients. However, approximately 60% of TNBC patients who received neoadjuvant chemotherapy fail to achieve pathological complete response and face significantly elevated risks of recurrence and distant metastasis. We have shown that chemotherapy can induce significant changes in TNBC tumor extracellular matrix (ECM) that drive tumor cell invasion and may contribute to recurrence. Here, we investigate how chemotherapy drugs can impact resident fibroblasts, the major generators of ECM in the breast tissue. We find that chemotherapy activates fibroblasts and that doxorubicin specifically induces the production of pro-invasive ECM by fibroblasts via TGF-\u03b2\/Smad3 signaling. An FDA-approved tyrosine kinase inhibitor nintedanib suppressed doxorubicin-induced fibroblast activation and pro-invasive ECM production by fibroblasts\n                  <jats:italic>in vitro<\/jats:italic>\n                  . Additionally, in a TNBC mouse model, nintedanib reduced fibroblast activation markers in tumors, suppressed tumor cell motility in the tumor ECM, and reduced lung metastasis. These findings demonstrate a novel mechanism by which chemotherapy can induce fibroblast activation and imply that targeting fibroblast activation reduces chemotherapy-induced metastasis in TNBC.\n                <\/jats:p>","DOI":"10.64898\/2026.09.04.749413","type":"posted-content","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T10:10:18Z","timestamp":1788862218000},"source":"Crossref","is-referenced-by-count":0,"title":["Targeting fibroblast activation suppresses chemotherapy-induced pro-invasive remodeling of the extracellular matrix"],"prefix":"10.64898","author":[{"given":"Anna","family":"Yui","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyi","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie C.","family":"Lew","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan J.","family":"Landau","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crystal","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"},{"name":"Department of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Gerton","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marissa","family":"Li","sequence":"additional","affiliation":[{"name":"Tufts University School of Medicine, Boston, MA 02111, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffy Jullian","family":"Guyard","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mallory M.","family":"Caron","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"},{"name":"Department of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackson P.","family":"Fatherree","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"McGinn","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7534-6354","authenticated-orcid":false,"given":"Abraham L.","family":"Bayer","sequence":"additional","affiliation":[{"name":"Department of Immunology, Tufts University School of Medicine, Boston, MA 02111, USA;"},{"name":"Immunology Graduate Program, Tufts University Graduate School of Biomedical Sciences, Boston, MA 02111, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-3982","authenticated-orcid":false,"given":"Pilar","family":"Alcaide","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Miami Miller School of Medicine, Miami, FL 33136, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7913-9619","authenticated-orcid":false,"given":"Charlotte","family":"Kuperwasser","sequence":"additional","affiliation":[{"name":"Department of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA;"},{"name":"Laboratory for the Convergence of Biomedical, Physical, and Engineering Sciences, Tufts University School of Medicine, Boston, MA 02111, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6988-4260","authenticated-orcid":false,"given":"Madeleine J.","family":"Oudin","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, School of Engineering, Tufts University, Medford, MA 02155, USA;"},{"name":"Department of Developmental, Molecular & Chemical Biology, Tufts University School of Medicine, Boston, MA 02111, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"54368","reference":[{"issue":"74","key":"2026091112551672000_2026.09.04.749413v1.1","first-page":"477","volume":"2024","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026091112551672000_2026.09.04.749413v1.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2112651"},{"key":"2026091112551672000_2026.09.04.749413v1.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2202809"},{"key":"2026091112551672000_2026.09.04.749413v1.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028485"},{"key":"2026091112551672000_2026.09.04.749413v1.5","unstructured":"Dent R , Shao Z , Schmid P , Cortes J , Cescon DW , Saji S , et al. Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial. Ann Oncol 2026"},{"key":"2026091112551672000_2026.09.04.749413v1.6","doi-asserted-by":"crossref","first-page":"e520506","DOI":"10.1200\/EDBK-26-520506","article-title":"Advanced Triple-Negative Breast Cancer: Emerging Therapies and a Changing Treatment Landscape","volume":"46","year":"2026","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2026091112551672000_2026.09.04.749413v1.7","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1405491"},{"key":"2026091112551672000_2026.09.04.749413v1.8","first-page":"523","volume-title":"Triple-Negative Breast Cancer on the Rise: Breakthroughs and Beyond. Breast Cancer","volume":"17","year":"2025"},{"key":"2026091112551672000_2026.09.04.749413v1.9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.4147"},{"key":"2026091112551672000_2026.09.04.749413v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)62422-8"},{"key":"2026091112551672000_2026.09.04.749413v1.11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.38.8595"},{"key":"2026091112551672000_2026.09.04.749413v1.12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.63.1010"},{"key":"2026091112551672000_2026.09.04.749413v1.13","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00589-1"},{"key":"2026091112551672000_2026.09.04.749413v1.14","doi-asserted-by":"crossref","first-page":"112935","DOI":"10.1016\/j.ejca.2023.05.023","article-title":"Real-world clinical and survival outcomes of patients with early relapsed triple-negative breast cancer from the ESME national cohort","volume":"189","year":"2023","journal-title":"Eur J Cancer"},{"key":"2026091112551672000_2026.09.04.749413v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.03.041"},{"key":"2026091112551672000_2026.09.04.749413v1.16","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-011-1895-2"},{"key":"2026091112551672000_2026.09.04.749413v1.17","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13058-015-0582-3","article-title":"Serial expression analysis of breast tumors during neoadjuvant chemotherapy reveals changes in cell cycle and immune pathways associated with recurrence and response","volume":"17","year":"2015","journal-title":"Breast cancer research : BCR"},{"key":"2026091112551672000_2026.09.04.749413v1.18","doi-asserted-by":"crossref","unstructured":"Vera-Ramirez L , Sanchez-Rovira P , Ramirez-Tortosa CL , Quiles JL , Ramirez-Tortosa M , Lorente JA . Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer Chemoresistance. PLoS ONE 2013;8","DOI":"10.1371\/journal.pone.0053983"},{"key":"2026091112551672000_2026.09.04.749413v1.19","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-020-00329-7"},{"key":"2026091112551672000_2026.09.04.749413v1.20","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1823"},{"key":"2026091112551672000_2026.09.04.749413v1.21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20162024"},{"key":"2026091112551672000_2026.09.04.749413v1.22","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1877"},{"key":"2026091112551672000_2026.09.04.749413v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39762-1"},{"key":"2026091112551672000_2026.09.04.749413v1.24","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0238-1"},{"key":"2026091112551672000_2026.09.04.749413v1.25","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0710"},{"key":"2026091112551672000_2026.09.04.749413v1.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-4827(02)00015-0"},{"key":"2026091112551672000_2026.09.04.749413v1.27","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2000.4869"},{"key":"2026091112551672000_2026.09.04.749413v1.28","doi-asserted-by":"crossref","unstructured":"Echeverria GV , Ge Z , Seth S , Zhang X , Jeter-Jones S , Zhou X , et al. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med 2019;11","DOI":"10.1126\/scitranslmed.aav0936"},{"key":"2026091112551672000_2026.09.04.749413v1.29","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.omto.2021.09.002","article-title":"Transcriptional landscape associated with TNBC resistance to neoadjuvant chemotherapy revealed by single-cell RNA-seq","volume":"23","year":"2021","journal-title":"Mol Ther Oncolytics"},{"key":"2026091112551672000_2026.09.04.749413v1.30","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-015-0582-3"},{"key":"2026091112551672000_2026.09.04.749413v1.31","doi-asserted-by":"publisher","DOI":"10.3892\/or.2011.1392"},{"key":"2026091112551672000_2026.09.04.749413v1.32","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201505891"},{"key":"2026091112551672000_2026.09.04.749413v1.33","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-009-0651-3"},{"key":"2026091112551672000_2026.09.04.749413v1.34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053983"},{"key":"2026091112551672000_2026.09.04.749413v1.35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0401064101"},{"key":"2026091112551672000_2026.09.04.749413v1.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2013.12.002"},{"key":"2026091112551672000_2026.09.04.749413v1.37","doi-asserted-by":"publisher","DOI":"10.1038\/nrc1317"},{"key":"2026091112551672000_2026.09.04.749413v1.38","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206933"},{"key":"2026091112551672000_2026.09.04.749413v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.146"},{"key":"2026091112551672000_2026.09.04.749413v1.40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024605"},{"key":"2026091112551672000_2026.09.04.749413v1.41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1013805107"},{"key":"2026091112551672000_2026.09.04.749413v1.42","doi-asserted-by":"crossref","first-page":"151524","DOI":"10.1016\/j.ejcb.2025.151524","article-title":"Revisiting single-cell migration parameters from 2D video microscopic measurements","volume":"105","year":"2026","journal-title":"Eur J Cell Biol"},{"key":"2026091112551672000_2026.09.04.749413v1.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2026091112551672000_2026.09.04.749413v1.44","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00174914"},{"key":"2026091112551672000_2026.09.04.749413v1.45","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2014-0445OC"},{"key":"2026091112551672000_2026.09.04.749413v1.46","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.23795"},{"key":"2026091112551672000_2026.09.04.749413v1.47","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/19420862.2015.1115166","article-title":"Development and characterization of human monoclonal antibodies that neutralize multiple TGFbeta isoforms","volume":"8","year":"2016","journal-title":"MAbs"},{"key":"2026091112551672000_2026.09.04.749413v1.48","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1734"},{"key":"2026091112551672000_2026.09.04.749413v1.49","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.01.011"},{"key":"2026091112551672000_2026.09.04.749413v1.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47068-z"},{"key":"2026091112551672000_2026.09.04.749413v1.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2013.06.016"},{"key":"2026091112551672000_2026.09.04.749413v1.52","doi-asserted-by":"crossref","unstructured":"Wishart AL , Conner SJ , Guarin JR , Fatherree JP , Peng Y , McGinn RA , et al. Decellularized extracellular matrix scaffolds identify full-length collagen VI as a driver of breast cancer cell invasion in obesity and metastasis. Sci Adv 2020;6","DOI":"10.1126\/sciadv.abc3175"},{"key":"2026091112551672000_2026.09.04.749413v1.53","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1158\/0008-5472.CAN-25-0966","article-title":"An Extracellular Matrix-Producing Subset of Cancer-Associated Fibroblasts Drives Chemoresistance in Breast Cancer via SRC Activation and G0S2 Upregulation","volume":"86","year":"2026","journal-title":"Cancer Res"},{"key":"2026091112551672000_2026.09.04.749413v1.54","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.3828"},{"key":"2026091112551672000_2026.09.04.749413v1.55","doi-asserted-by":"crossref","unstructured":"Hopkins B , Torres M . Radiotherapy in Triple Negative Breast Cancer \u2013 Current Standards and Future Directions. Current Breast Cancer Reports 2024;17","DOI":"10.1007\/s12609-024-00565-y"},{"key":"2026091112551672000_2026.09.04.749413v1.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2026.117096"},{"key":"2026091112551672000_2026.09.04.749413v1.57","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00048.2019"},{"key":"2026091112551672000_2026.09.04.749413v1.58","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.12.9.2730"},{"key":"2026091112551672000_2026.09.04.749413v1.59","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74179-6"},{"key":"2026091112551672000_2026.09.04.749413v1.60","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2756"},{"key":"2026091112551672000_2026.09.04.749413v1.61","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/cac2.12392","article-title":"Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives","volume":"43","year":"2023","journal-title":"Cancer Commun (Lond"},{"key":"2026091112551672000_2026.09.04.749413v1.62","doi-asserted-by":"publisher","DOI":"10.1038\/srep19276"},{"key":"2026091112551672000_2026.09.04.749413v1.63","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-04317-0"},{"key":"2026091112551672000_2026.09.04.749413v1.64","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-014-0157-3"},{"key":"2026091112551672000_2026.09.04.749413v1.65","doi-asserted-by":"crossref","unstructured":"Peterson JM , Jay JW , Wang Y , Joglar AA , Prasai A , Palackic A , et al. Galunisertib Exerts Antifibrotic Effects on TGF-beta-Induced Fibroproliferative Dermal Fibroblasts. Int J Mol Sci 2022;23","DOI":"10.3390\/ijms23126689"},{"key":"2026091112551672000_2026.09.04.749413v1.66","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-018-0085-z"},{"key":"2026091112551672000_2026.09.04.749413v1.67","first-page":"571158","article-title":"FGF7-FGFR2 Signaling Enhances Contractile Activation of CAFs in Ovarian Cancer: Integrative Single-Cell and Spatial Transcriptomics","volume":"19","year":"2026","journal-title":"J Inflamm Res"},{"key":"2026091112551672000_2026.09.04.749413v1.68","doi-asserted-by":"crossref","first-page":"102194","DOI":"10.1016\/j.omtn.2024.102194","article-title":"miR-200-mediated inactivation of cancer-associated fibroblasts via targeting of NRP2-VEGFR signaling attenuates lung cancer invasion and metastasis","volume":"35","year":"2024","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026091112551672000_2026.09.04.749413v1.69","doi-asserted-by":"crossref","first-page":"118952","DOI":"10.1016\/j.biopha.2025.118952","article-title":"Modeling cancer-associated fibroblast plasticity and breast cancer interactions using patient-derived scaffolds","volume":"194","year":"2026","journal-title":"Biomed Pharmacother"},{"key":"2026091112551672000_2026.09.04.749413v1.70","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05085-y"},{"key":"2026091112551672000_2026.09.04.749413v1.71","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/cvr\/cvag098","article-title":"STING promotes CD8 T-cell cardiotropism and fibrosis from distinct cellular compartments in doxorubicin cardiomyopathy","volume":"122","year":"2026","journal-title":"Cardiovasc Res"},{"key":"2026091112551672000_2026.09.04.749413v1.72","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00545.2023"},{"key":"2026091112551672000_2026.09.04.749413v1.73","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(13)70586-2"},{"key":"2026091112551672000_2026.09.04.749413v1.74","unstructured":"2015 Overcoming Drug Resistance in Metastatic Castration-resistant Prostate Cancer With Novel Combination of TGF-\u03b2 Receptor Inhibitor LY2157299 and Enzalutamide: a Randomized Multi- site Phase II Study. <https:\/\/clinicaltrials.gov\/study\/NCT02452008>."},{"key":"2026091112551672000_2026.09.04.749413v1.75","unstructured":"2025 Exploratory Clinical Study of Camrelizumab Combined With Pirfenidone and Chemotherapy in the Treatment of Advanced Triple-Negative Breast Cancer. <https:\/\/clinicaltrials.gov\/study\/NCT07161791>."},{"key":"2026091112551672000_2026.09.04.749413v1.76","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2379"},{"key":"2026091112551672000_2026.09.04.749413v1.77","doi-asserted-by":"publisher","DOI":"10.1038\/nature10694"},{"key":"2026091112551672000_2026.09.04.749413v1.78","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/s43018-022-00353-6","article-title":"Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro- metastatic vascular niche in the lungs","volume":"3","year":"2022","journal-title":"Nat Cancer"},{"key":"2026091112551672000_2026.09.04.749413v1.79","doi-asserted-by":"publisher","DOI":"10.1016\/j.matbio.2022.08.002"},{"key":"2026091112551672000_2026.09.04.749413v1.80","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-21-1012"},{"key":"2026091112551672000_2026.09.04.749413v1.81","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.113.208223"},{"key":"2026091112551672000_2026.09.04.749413v1.82","doi-asserted-by":"crossref","first-page":"109409","DOI":"10.1016\/j.intimp.2022.109409","article-title":"Nintedanib alleviates pulmonary fibrosis in vitro and in vivo by inhibiting the FAK\/ERK\/S100A4 signalling pathway","volume":"113","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"2026091112551672000_2026.09.04.749413v1.83","doi-asserted-by":"crossref","first-page":"026112","DOI":"10.1063\/1.5019196","article-title":"Anomalously diffusing and persistently migrating cells in 2D and 3D culture environments.","volume":"2","year":"2018","journal-title":"APL Bioeng"},{"key":"2026091112551672000_2026.09.04.749413v1.84","doi-asserted-by":"publisher","DOI":"10.1016\/bs.mcb.2019.11.014"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.09.04.749413","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T19:55:33Z","timestamp":1789156533000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.64898\/2026.09.04.749413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":84,"URL":"https:\/\/doi.org\/10.64898\/2026.09.04.749413","relation":{},"subject":[],"published":{"date-parts":[[2026,9,8]]},"subtype":"preprint"}}